查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888867

RNAi技術市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測（2025-2033年）

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

RNAi技術市場摘要

2024年全球RNAi技術市場規模估計為29.4億美元，預計2033年將達到95.2億美元。

預計從 2025 年到 2033 年，該市場將以 14.25% 的複合年成長率成長。推動這一市場成長的因素是全球自體免疫疾病、罕見疾病和癌症的盛行率不斷上升。

基於RNAi的療法的擴展

RNAi技術市場正憑藉強力的臨床檢驗和多項FDA/EMA核准（包括ONPATTRO、GIVLAARI、OXLUMO和AMVUTTRA）而快速成長。這些核准表明RNAi可以開發成安全有效的療法，增強了生物製藥公司的信心，並加速了對RNAi平台的投資。 RNAi能夠精準地沉默致病基因，使其成為治療罕見遺傳疾病和肝臟標靶疾病的創新選擇。隨著已通過核准的RNAi療法展現出強大的臨床和商業性成功，對RNAi工具、試劑和遞送技術的需求持續成長。

市場成長也受到製藥業濃厚興趣的進一步推動。 Alnylam、Arrowhead、Dicerna（諾和諾德）、阿斯特捷利康和武田製藥等公司正透過合作、收購和內部研發拓展其RNAi產品線。這些努力正在將RNAi的應用範圍擴展到腫瘤學、感染疾病和心血管代謝疾病領域。大量的投資、持續的合作以及專業的RNAi研究設施正在推動臨床活動、產品上市和持續創新。隨著治療產品線的擴展和產業投資的增加，藥物發現和臨床開發中對RNAi平台的需求日益成長。

配送技術的進步

RNAi遞送系統的進步一直是RNAi技術產業發展的主要驅動力。傳統上存在的許多挑戰，例如攝取效率低、分解迅速和脫靶效應等，已透過脂質奈米顆粒（LNP）、GalNAc-siRNA偶聯物、聚合物載體和病毒載體等創新技術有效克服。這些新一代平台具有更高的穩定性、生物分佈和組織特異性標靶化，尤其是在肝臟中——遺傳和代謝疾病的主要發病部位。隨著遞送效率的提高和臨床可行性的增強，對RNAi試劑、遞送試劑盒和開發解決方案的需求持續成長。

此外，先進的遞送技術正在拓展RNAi的應用範圍，使其不再局限於肝臟標靶。定向奈米顆粒、肽基載體和工程化外泌體等新型策略，為感染疾病、癌症和中樞神經系統疾病的治療創造了新的應用機會。為了增強產品線並降低研發風險，生物製藥公司正大力投資這些遞送創新技術。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析

第4章 RNAi技術市場：按產品和服務分類的業務分析

  • 全球RNAi技術市場按產品和服務分類的變化分析
  • 全球RNAi技術市場規模及趨勢分析（依產品/服務分類，2021-2033年）
  • 產品
  • 服務

第5章 RNAi技術市場：按應用分類的業務分析

  • 依應用分析全球RNAi技術市場的變化
  • 全球RNAi技術市場規模及趨勢分析（依應用領域分類，2021-2033年）
  • 藥物發現與開發
  • 功能基因體學
  • 其他

第6章：RNAi技術市場：依最終用途分類的業務分析

  • 全球RNAi技術市場最終用途變化分析
  • 全球RNAi技術市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 製藥和生物技術公司
  • 學術和研究機構
  • 合約研究組織 (CRO) 和合約生產組織 (CMO)

第7章 RNAi技術市場：按產品/服務、應用和最終用途分類的估算和趨勢分析（按地區）

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業
  • 策略規劃
  • 企業市場分析（2024）
  • 參與公司概況
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Creative Biolabs
    • GenScript
    • Revvity
    • Promega Corporation
    • OriGene Technologies, Inc.
    • Altogen Biosystems
    • Danaher
    • Bioneer Corporation
Product Code: GVR-4-68040-295-6

RNAi Technology Market Summary

The global RNAi technology market size was estimated at USD 2.94 billion in 2024 and is projected to reach USD 9.52 billion by 2033, growing at a CAGR of 14.25% from 2025 to 2033. This market growth is attributed to the increasing prevalence of autoimmune diseases, rare disorders, and cancer across the globe.

Expansion of RNAi-Based Therapeutics

The RNAi technology market is growing rapidly due to strong clinical validation and multiple FDA/EMA approvals, including ONPATTRO, GIVLAARI, OXLUMO, and AMVUTTRA. These approvals have proven that RNAi can be developed into safe and effective therapeutics, boosting confidence among biopharma companies and accelerating investment in RNAi platforms. Its ability to precisely silence disease-causing genes makes RNAi a transformative option for rare genetic and liver-targeted disorders. As approved RNAi therapies show strong clinical and commercial performance, demand for RNAi tools, reagents, and delivery technologies continues to rise.

The growth of the market is being further accelerated by significant pharmaceutical interest. Through partnerships, acquisitions, and internal research and development, businesses such as Alnylam, Arrowhead, Dicerna (Novo Nordisk), AstraZeneca, and Takeda are growing their RNAi pipelines. Through these initiatives, RNAi applications are expanding into the fields of oncology, infectious diseases, and cardiometabolic disorders. Significant investments, enduring collaborations, and specialized RNAi research facilities are propelling clinical activity, product launches, and ongoing innovation. The need for RNAi platforms in drug discovery and clinical development keeps growing as the therapeutic pipeline broadens and industry investment increases.

Advancements in Delivery Technologies

Advances in RNAi delivery systems have become a key growth driver for the RNAi technology industry. Earlier issues, such as poor uptake, rapid degradation, and off-target effects, have been largely addressed through innovations in LNPs, GalNAc-siRNA conjugates, polymer carriers, and viral vectors. These next-generation platforms enhance stability, biodistribution, and tissue-specific targeting, particularly in the liver, a major site for genetic and metabolic disorders. As delivery becomes more efficient and clinically viable, demand for RNAi reagents, delivery kits, and development solutions continues to increase.

In addition, RNAi is expanding beyond liver targets owing to advanced delivery technologies. New strategies, such as targeted nanoparticles, peptide-based carriers, and engineered exosomes, are creating opportunities for applications in infectious diseases, cancer, and the central nervous system. To improve their pipelines and lower development risk, biopharma companies are making significant investments in these delivery innovations.

Global RNAi Technology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global RNAi technology market report on the basis of product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Products
    • miRNA
    • siRNA
    • Others
  • Service
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
    • Neurology
    • Oncology
    • Infectious Diseases
    • Metabolic Diseases
    • Others
  • Functional Genomics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion of RNAi-based therapeutics
      • 3.2.1.2. Advancements in delivery technologies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals and research support in developing countries
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global RNAi Technology Market Product & Service Movement Analysis
  • 4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Products
    • 4.4.1. Global Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. miRNA
      • 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. siRNA
      • 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global RNAi Technology Market Application, Movement Analysis
  • 5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Neurology
      • 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Infectious Diseases
      • 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Metabolic Diseases
      • 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Functional Genomics
    • 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. RNAi Technology Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Global RNAi Technology Market End Use Movement Analysis
  • 6.3. Global RNAi Technology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, & End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Participant's Overview
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Creative Biolabs
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Revvity
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Altogen Biosystems
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Danaher
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bioneer Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global RNAi technology market, by region, 2021 - 2033 (USD Million)
  • Table 7 North America RNAi technology market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 9 North America RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 10 North America RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 11 U.S. RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 12 U.S. RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 13 U.S. RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 14 Canada RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 15 Canada RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Mexico RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 18 Mexico RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe RNAi technology market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 22 Europe RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 24 UK RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 25 UK RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 26 UK RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 28 Germany RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 29 Germany RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 30 France RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 31 France RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 32 France RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Italy RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 34 Italy RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 35 Italy RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Spain RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 37 Spain RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Denmark RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 40 Denmark RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 41 Denmark RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 42 Sweden RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 43 Sweden RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 44 Sweden RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Norway RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 46 Norway RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 47 Norway RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific RNAi technology market, by country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Japan RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 53 Japan RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 54 Japan RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 55 China RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 56 China RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 57 China RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 59 India RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 60 India RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Australia RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 62 Australia RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 63 Australia RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Thailand RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 65 Thailand RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 66 Thailand RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 67 South Korea RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 68 South Korea RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 69 South Korea RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Latin America RNAi technology market, by country, 2021 - 2033 (USD Million)
  • Table 71 Latin America RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 72 Latin America RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 73 Latin America RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Brazil RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 75 Brazil RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 76 Brazil RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Argentina RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 78 Argentina RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 79 Argentina RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa RNAi technology market, by country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 84 South Africa RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 85 South Africa RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 86 South Africa RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 90 UAE RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 91 UAE RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 92 UAE RNAi technology market, by end use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait RNAi technology market, by product & service, 2021 - 2033 (USD Million)
  • Table 94 Kuwait RNAi technology market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait RNAi technology market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 RNAi technology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 RNAi technology market driver analysis
  • Fig. 12 RNAi technology market restraint analysis
  • Fig. 13 RNAi technology market: Porter's analysis
  • Fig. 14 RNAi technology market: PESTEL analysis
  • Fig. 15 RNAi technology market: Product & Service outlook and key takeaways
  • Fig. 16 RNAi technology market: Product & Service market share analysis
  • Fig. 17 Global RNAi technology by products market, 2021 - 2033 (USD Million)
  • Fig. 18 Global RNAi technology by miRNA market, 2021 - 2033 (USD Million)
  • Fig. 19 Global RNAi technology by siRNA market, 2021 - 2033 (USD Million)
  • Fig. 20 Global RNAi technology by others market, 2021 - 2033 (USD Million)
  • Fig. 21 Global RNAi technology by service market, 2021 - 2033 (USD Million)
  • Fig. 22 RNAi technology market: Application outlook and key takeaways
  • Fig. 23 RNAi technology market: Application market share analysis
  • Fig. 24 Global RNAi technology by drug discovery & development market, 2021 - 2033 (USD Million)
  • Fig. 25 Global RNAi technology by neurology market, 2021 - 2033 (USD Million)
  • Fig. 26 Global RNAi technology by oncology market, 2021 - 2033 (USD Million)
  • Fig. 27 Global RNAi technology by infectious diseases market, 2021 - 2033 (USD Million)
  • Fig. 28 Global RNAi technology by metabolic diseases market, 2021 - 2033 (USD Million)
  • Fig. 29 Global RNAi technology by others market, 2021 - 2033 (USD Million)
  • Fig. 30 Global RNAi technology by functional genomics market, 2021 - 2033 (USD Million)
  • Fig. 31 Global RNAi technology others market, 2021 - 2033 (USD Million)
  • Fig. 32 RNAi technology market: End Use outlook and key takeaways
  • Fig. 33 RNAi technology market: End Use market share analysis
  • Fig. 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 35 Global RNAi technology by academic & research institutes market, 2021 - 2033 (USD Million)
  • Fig. 36 Global RNAi technology by CROs & CMOs market, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Canada RNAi technology market, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Europe RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 UK RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Germany RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 France RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Italy RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Spain RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Norway RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Japan RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 China RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 India RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Australia RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Argentina RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Middle East & Africa RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 UAE RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait RNAi technology market estimates and forecast, 2021 - 2033 (USD Million)